克洛纳泽帕姆在状态中充满剂量:更多总是更好吗?
Jennifer D'Anto1, Isabelle Beuchat2, Andrea O Rossetti2
1Department of Internal Medicine, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
CNS drugs
|June 8, 2023
概括
在状态 (SE) 中,二胺的低剂量是常见的. 这项研究发现,克罗纳泽帕姆 (CLZ) 充满剂量不会影响SE的结果,这表明个性化剂量可能是适当的.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 二是第一线治疗状态 (SE) 的药物.
- 在SE中低剂量服用二可以产生负面后果.
- 克罗纳泽 (CLZ) 是一些欧洲国家常用的一线药物.
研究的目的:
- 调查克罗纳泽帕姆 (CLZ) 充满剂量与状态 (SE) 结果之间的相关性.
- 为了确定更高的CLZ负载剂量是否与改善的SE治疗反应有关.
- 在SE管理中探索影响CLZ剂量的因素.
主要方法:
- 对用CLZ治疗的SE发作预期注册表的回顾性分析.
- 包括接受CLZ作为一线治疗的成年患者 (年龄大于16岁).
- 结果分析包括治疗线,耐火性状态,输管率和死亡率,与CLZ负载剂量相关 (≥0.015 mg/kg被认为是高).
主要成果:
- 总共分析了251次SE发作;中位数的CLZ负载剂量为0.010 mg/kg.
- 高的CLZ负载剂量与年龄较小,体重较低以及用于气道保护的输管增加有关.
- 不同的CLZ负载剂量和SE结果参数之间没有发现显著的关联.
结论:
- 较高的克罗纳泽帕姆 (CLZ) 加载剂量与改善状态 (SE) 结果无关.
- 这些发现表明,目前推的CLZ剂量可能超过某些患者的要求.
- 基于临床背景的个性化CLZ剂量建议用于SE治疗.
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
219
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
219
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
473
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
473
01:17Antiepileptic Drugs: Calcium Channel Blockers
475
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
475
01:08Antiepileptic Drugs: Sodium Channel Blockers
696
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
696
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
351
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
351
01:26Psychosis: Goals of Pharmacotherapy
172
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
172